159 related articles for article (PubMed ID: 37379068)
1. Virtual pretreatment patient-specific quality assurance of volumetric modulated arc therapy using deep learning.
Yoganathan SA; Ahmed S; Paloor S; Torfeh T; Aouadi S; Al-Hammadi N; Hammoud R
Med Phys; 2023 Dec; 50(12):7891-7903. PubMed ID: 37379068
[TBL] [Abstract][Full Text] [Related]
2. A synthesized gamma distribution-based patient-specific VMAT QA using a generative adversarial network.
Matsuura T; Kawahara D; Saito A; Yamada K; Ozawa S; Nagata Y
Med Phys; 2023 Apr; 50(4):2488-2498. PubMed ID: 36609669
[TBL] [Abstract][Full Text] [Related]
3. Efficient dose-volume histogram-based pretreatment patient-specific quality assurance methodology with combined deep learning and machine learning models for volumetric modulated arc radiotherapy.
Gong C; Zhu K; Lin C; Han C; Lu Z; Chen Y; Yu C; Hou L; Zhou Y; Yi J; Ai Y; Xiang X; Xie C; Jin X
Med Phys; 2022 Dec; 49(12):7779-7790. PubMed ID: 36190117
[TBL] [Abstract][Full Text] [Related]
4. Error detection model developed using a multi-task convolutional neural network in patient-specific quality assurance for volumetric-modulated arc therapy.
Kimura Y; Kadoya N; Oku Y; Kajikawa T; Tomori S; Jingu K
Med Phys; 2021 Sep; 48(9):4769-4783. PubMed ID: 34101848
[TBL] [Abstract][Full Text] [Related]
5. Detecting MLC modeling errors using radiomics-based machine learning in patient-specific QA with an EPID for intensity-modulated radiation therapy.
Sakai M; Nakano H; Kawahara D; Tanabe S; Takizawa T; Narita A; Yamada T; Sakai H; Ueda M; Sasamoto R; Kaidu M; Aoyama H; Ishikawa H; Utsunomiya S
Med Phys; 2021 Mar; 48(3):991-1002. PubMed ID: 33382467
[TBL] [Abstract][Full Text] [Related]
6. Deep learning-based tools to distinguish plan-specific from generic deviations in EPID-based in vivo dosimetry.
Olaciregui-Ruiz I; Simões R; Jan-Jakob S
Med Phys; 2024 Feb; 51(2):854-869. PubMed ID: 38112213
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of prediction and classification performances in different machine learning models for patient-specific quality assurance of head-and-neck VMAT plans.
Kusunoki T; Hatanaka S; Hariu M; Kusano Y; Yoshida D; Katoh H; Shimbo M; Takahashi T
Med Phys; 2022 Jan; 49(1):727-741. PubMed ID: 34859445
[TBL] [Abstract][Full Text] [Related]
8. Development of a deep learning-based error detection system without error dose maps in the patient-specific quality assurance of volumetric modulated arc therapy.
Kimura Y; Kadoya N; Oku Y; Jingu K
J Radiat Res; 2023 Jul; 64(4):728-737. PubMed ID: 37177789
[TBL] [Abstract][Full Text] [Related]
9. Patient-specific quality assurance prediction models based on machine learning for novel dual-layered MLC linac.
Zhu H; Zhu Q; Wang Z; Yang B; Zhang W; Qiu J
Med Phys; 2023 Feb; 50(2):1205-1214. PubMed ID: 36342293
[TBL] [Abstract][Full Text] [Related]
10. Deep Learning for Patient-Specific Quality Assurance: Predicting Gamma Passing Rates for IMRT Based on Delivery Fluence Informed by log Files.
Huang Y; Pi Y; Ma K; Miao X; Fu S; Zhu Z; Cheng Y; Zhang Z; Chen H; Wang H; Gu H; Shao Y; Duan Y; Feng A; Zhuo W; Xu Z
Technol Cancer Res Treat; 2022; 21():15330338221104881. PubMed ID: 35726209
[No Abstract] [Full Text] [Related]
11. Clinical VMAT machine parameter optimization for localized prostate cancer using deep reinforcement learning.
Hrinivich WT; Bhattacharya M; Mekki L; McNutt T; Jia X; Li H; Song DY; Lee J
Med Phys; 2024 Jun; 51(6):3972-3984. PubMed ID: 38669457
[TBL] [Abstract][Full Text] [Related]
12. A TPS integrated machine learning tool for predicting patient-specific quality assurance outcomes in volumetric-modulated arc therapy.
Noblet C; Maunet M; Duthy M; Coste F; Moreau M
Phys Med; 2024 Feb; 118():103208. PubMed ID: 38211462
[TBL] [Abstract][Full Text] [Related]
13. An in vivo dose verification method for SBRT-VMAT delivery using the EPID.
McCowan PM; Van Uytven E; Van Beek T; Asuni G; McCurdy BM
Med Phys; 2015 Dec; 42(12):6955-63. PubMed ID: 26632051
[TBL] [Abstract][Full Text] [Related]
14. Predictive gamma passing rate of 3D detector array-based volumetric modulated arc therapy quality assurance for prostate cancer via deep learning.
Matsuura T; Kawahara D; Saito A; Miura H; Yamada K; Ozawa S; Nagata Y
Phys Eng Sci Med; 2022 Dec; 45(4):1073-1081. PubMed ID: 36202950
[TBL] [Abstract][Full Text] [Related]
15. A method to reconstruct and apply 3D primary fluence for treatment delivery verification.
Liu S; Mazur TR; Li H; Curcuru A; Green OL; Sun B; Mutic S; Yang D
J Appl Clin Med Phys; 2017 Jan; 18(1):128-138. PubMed ID: 28291913
[TBL] [Abstract][Full Text] [Related]
16. Multi-task autoencoder based classification-regression model for patient-specific VMAT QA.
Wang L; Li J; Zhang S; Zhang X; Zhang Q; Chan MF; Yang R; Sui J
Phys Med Biol; 2020 Nov; 65(23):235023. PubMed ID: 33245054
[TBL] [Abstract][Full Text] [Related]
17. Prediction of patient-specific quality assurance for volumetric modulated arc therapy using radiomics-based machine learning with dose distribution.
Ishizaka N; Kinoshita T; Sakai M; Tanabe S; Nakano H; Tanabe S; Nakamura S; Mayumi K; Akamatsu S; Nishikata T; Takizawa T; Yamada T; Sakai H; Kaidu M; Sasamoto R; Ishikawa H; Utsunomiya S
J Appl Clin Med Phys; 2024 Jan; 25(1):e14215. PubMed ID: 37987544
[TBL] [Abstract][Full Text] [Related]
18. Machine Learning for Patient-Specific Quality Assurance of VMAT: Prediction and Classification Accuracy.
Li J; Wang L; Zhang X; Liu L; Li J; Chan MF; Sui J; Yang R
Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):893-902. PubMed ID: 31377162
[TBL] [Abstract][Full Text] [Related]
19. A novel method for sub-arc VMAT dose delivery verification based on portal dosimetry with an EPID.
Cools RAM; Dirkx MLP; Heijmen BJM
Med Phys; 2017 Nov; 44(11):5556-5562. PubMed ID: 28815696
[TBL] [Abstract][Full Text] [Related]
20. Using machine learning to predict gamma passing rate in volumetric-modulated arc therapy treatment plans.
Salari E; Shuai Xu K; Sperling NN; Parsai EI
J Appl Clin Med Phys; 2023 Feb; 24(2):e13824. PubMed ID: 36495010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
